Pharma Industrial India

Dear Readers, Pharma Industrial India Magazine is happy to share its latest work i.e January-February 2024 issue with you. The issue brings standalone thought leadership from: Puunam G Kaushik, Deputy Managing Director and Chief Corporate Affairs, Meteoric Biopharmaceuticals Pvt. Ltd. ; Jashan Bhumkar, Director, Soujanya Lifesciences The issue also offers insight into various sectors through thought pieces from various industry pioneers and accelerators: Abhishek Batni, Consultant; Prashant VV, Consultant, Avalon Consulting; Sehgal Madhur, Head of Climate Solutions, Danfoss India Region; Do read the complete magazine here: https://lnkd.in/dwUQfr6q We hope you enjoy our work!!! #biotech #india #healthcare #manufacturing #drugsanddevelopment #equipment #treatment #biotechnology #globalpharma #pharmaceuticals #PharmaIndustrialIndia

Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older. David Ricardo Munoz Guzman mauricio botero caicedo #healthcare #PharmaIndustrialIndia

Life Molecular Imaging (LMI) has expanded their strategic partnership and licensing agreement with Jubilant Radiopharma to provide and distribute Neuraceq from Jubilant's single photon emission computed tomography (SPECT) and Positron Emision Tomography (PET) #radiopharmaceutical #manufacturing site located in Mobile, AL. Renato Leite #healthcare #PharmaIndustrialIndia

MedPharm Ltd has announced a merger with Tergus Pharma, a Great Point Partners portfolio company. Michael Kane Patrick Walsh #healthcare #PharmaIndustrialIndia

Lupin has secured tentative approval from the United States Food and Drug Administration (US FDA)for its Abbreviated New Drug Application for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release (ER) Tablets. #healthcare #PharmaIndustrialIndia

TuHURA Biosciences, Inc. has entered into an Exclusivity and Right of First Offer Agreement with Kineta for the potential acquisition of Kineta's KVA12123 anti-VISTA antibody and related rights and assets associated with and derived from the asset. James A. Bianco, MD #healthcare #PharmaIndustrialIndia

CASI Pharmaceuticals, Inc. has #appointed Dan Lang, MD, MD as Chief Financial Officer and Senior Vice President. Wei-Wu He, Ph. D. #healthcare #PharmaIndustrialIndia

Eli Lilly and Company has signed a #definitivagreement to acquire Morphic Therapeutic, a #biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases. Daniel Skovronsky Praveen Tipirneni #healthcare #PharmaIndustrialIndia

Porton J-STAR has announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on ‘Co-processing Platform Technology’. #healthcare #PharmaIndustrialIndia

Myricx Bio has raised EUR 90 Million (USD 114 Million) in the latest Series A #financing round. Robin Carr #healthcare #PharmaIndustrialIndia